BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

329 related articles for article (PubMed ID: 23992306)

  • 1. Resveratrol inhibits the epithelial-mesenchymal transition of pancreatic cancer cells via suppression of the PI-3K/Akt/NF-κB pathway.
    Li W; Ma J; Ma Q; Li B; Han L; Liu J; Xu Q; Duan W; Yu S; Wang F; Wu E
    Curr Med Chem; 2013; 20(33):4185-4194. PubMed ID: 23992306
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
    Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
    BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
    Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
    Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol Inhibits the Migration and Metastasis of MDA-MB-231 Human Breast Cancer by Reversing TGF-β1-Induced Epithelial-Mesenchymal Transition.
    Sun Y; Zhou QM; Lu YY; Zhang H; Chen QL; Zhao M; Su SB
    Molecules; 2019 Mar; 24(6):. PubMed ID: 30901941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
    Zhu J; Wen K
    Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blocking PI3K/Akt signaling attenuates metastasis of nasopharyngeal carcinoma cells through induction of mesenchymal-epithelial reverting transition.
    Jiang H; Gao M; Shen Z; Luo B; Li R; Jiang X; Ding R; Ha Y; Wang Z; Jie W
    Oncol Rep; 2014 Aug; 32(2):559-66. PubMed ID: 24889918
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ginkgolic Acid Inhibits Invasion and Migration and TGF-β-Induced EMT of Lung Cancer Cells Through PI3K/Akt/mTOR Inactivation.
    Baek SH; Ko JH; Lee JH; Kim C; Lee H; Nam D; Lee J; Lee SG; Yang WM; Um JY; Sethi G; Ahn KS
    J Cell Physiol; 2017 Feb; 232(2):346-354. PubMed ID: 27177359
    [TBL] [Abstract][Full Text] [Related]  

  • 9. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
    Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
    Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel anti‑cancer effect of resveratrol: reversal of epithelial‑mesenchymal transition in prostate cancer cells.
    Li J; Chong T; Wang Z; Chen H; Li H; Cao J; Zhang P; Li H
    Mol Med Rep; 2014 Oct; 10(4):1717-24. PubMed ID: 25069516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M; Zhang B; Zhang Y; Li J; Su L; Zhu Z; Gu Q; Liu B; Yan M
    PLoS One; 2014; 9(11):e112908. PubMed ID: 25398131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alisertib induces cell cycle arrest and autophagy and suppresses epithelial-to-mesenchymal transition involving PI3K/Akt/mTOR and sirtuin 1-mediated signaling pathways in human pancreatic cancer cells.
    Wang F; Li H; Yan XG; Zhou ZW; Yi ZG; He ZX; Pan ST; Yang YX; Wang ZZ; Zhang X; Yang T; Qiu JX; Zhou SF
    Drug Des Devel Ther; 2015; 9():575-601. PubMed ID: 25632225
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superoxide dismutase promotes the epithelial-mesenchymal transition of pancreatic cancer cells via activation of the H2O2/ERK/NF-κB axis.
    Li W; Cao L; Han L; Xu Q; Ma Q
    Int J Oncol; 2015; 46(6):2613-20. PubMed ID: 25825208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Curcumin inhibits hypoxia-induced epithelial‑mesenchymal transition in pancreatic cancer cells via suppression of the hedgehog signaling pathway.
    Cao L; Xiao X; Lei J; Duan W; Ma Q; Li W
    Oncol Rep; 2016 Jun; 35(6):3728-34. PubMed ID: 27035865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. α-Mangostin suppresses the viability and epithelial-mesenchymal transition of pancreatic cancer cells by downregulating the PI3K/Akt pathway.
    Xu Q; Ma J; Lei J; Duan W; Sheng L; Chen X; Hu A; Wang Z; Wu Z; Wu E; Ma Q; Li X
    Biomed Res Int; 2014; 2014():546353. PubMed ID: 24812621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Curcumin attenuates hyperglycemia-driven EGF-induced invasive and migratory abilities of pancreatic cancer via suppression of the ERK and AKT pathways.
    Li W; Wang Z; Xiao X; Han L; Wu Z; Ma Q; Cao L
    Oncol Rep; 2019 Jan; 41(1):650-658. PubMed ID: 30542713
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Induction of the Epithelial-to-Mesenchymal Transition of Human Colorectal Cancer by Human TNF-β (Lymphotoxin) and its Reversal by Resveratrol.
    Buhrmann C; Yazdi M; Popper B; Kunnumakkara AB; Aggarwal BB; Shakibaei M
    Nutrients; 2019 Mar; 11(3):. PubMed ID: 30917533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.
    Li W; Cao L; Chen X; Lei J; Ma Q
    Oncol Rep; 2016 Mar; 35(3):1718-26. PubMed ID: 26707376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [P2Y purinergic receptor activated PI-3K/Akt signaling pathway in regulation of growth and invasion of prostatic cancer].
    Wang YX; Shi YH; Gong LH; Li Y; Heng WJ; You JF; Zhong HH; Fang WG
    Zhonghua Bing Li Xue Za Zhi; 2007 Oct; 36(10):681-6. PubMed ID: 18194602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.